Moneycontrol Be a Pro
Get App
SENSEX NIFTY
you are here:

RPG Life Sciences Ltd.

BSE Live

Dec 13, 16:00
293.00 1.20 (0.41%)
Volume
AVERAGE VOLUME
5-Day
5,201
10-Day
5,776
30-Day
11,551
8,499
  • Prev. Close

    291.80

  • Open Price

    292.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Dec 13, 15:54
292.85 1.75 (0.60%)
Volume
AVERAGE VOLUME
5-Day
38,993
10-Day
47,052
30-Day
91,393
84,410
  • Prev. Close

    291.10

  • Open Price

    294.90

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    292.85 (99)

ANNOUNCEMENTS ON RPG Life

  • Dec 06, 2019 12:29 Source: BSE

    RPG Life Sciences - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    We wish to inform you that on December 6, 2019, we have received application for Loss of Share Certificate through RTA Link Intime India Private Limited. A copy of the email received from RTA is enclosed herewith for your reference. Kindly take the same on record.

  • Nov 28, 2019 13:30 Source: NSE

    RPG Life Sciences Limited

    RPG Life Sciences Limited has submitted to the Exchange a copy of disclosure of Related Party Transactions for the half year ended September 30, 2019.

  • Nov 28, 2019 12:40 Source: BSE

    RPG Life Sciences - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    We wish to inform you that on November 28, 2019, we have received application for Loss of Share Certificate through RTA Link Intime India Private Limited. A copy of the email received from RTA is enclosed herewith for your reference Kindly take the same on record

  • Nov 28, 2019 12:35 Source: BSE

    RPG Life Sciences - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.

    In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Regulations and Disclosure Requirements) Regulations, 2015, we enclose herewith disclosure of Related Party Transactions, in the format specified in the accounting standards for the half year ended September 30, 2019. Kindly take the same on record.

  • Oct 31, 2019 16:40 Source: NSE

    RPG Life Sciences Limited

    RPG Life Sciences Limited has informed the Exchange regarding 'In terms of the Regulation 30 read with Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the newspaper publications with respect to Unaudited Financial Results for the quarter and half year ended September 30, 2019.Kindly take the same on record.'.

  • Oct 31, 2019 16:24 Source: BSE

    RPG Life Sciences - Announcement under Regulation 30 (LODR)-Newspaper Publication

    In terms of the Regulation 30 read with Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the newspaper publications with respect to Unaudited Financial Results for the quarter and half year ended September 30, 2019. Kindly take the same on record.

  • Oct 30, 2019 17:08 Source: BSE

    RPG Life Sciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    Please find enclosed herewith a copy of press release with respect to Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2019. Kindly take the above on record.

  • Oct 30, 2019 16:15 Source: BSE

    RPG Life Sciences - Results For The Quarter And Half Year Ended September 30, 2019

    Pursuant to Regulation 33 Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Unaudited Financial Results for the quarter and half year ended September 30, 2019 which were approved by the Board of Directors of the Company, at its meeting held on October 30, 2019 along with Limited Review Report issued by the Statutory Auditors of the Company. The meeting commenced at 12:00 noon and concluded at 4:00 p.m. Kindly take the above on record.

  • Oct 30, 2019 16:09 Source: BSE

    RPG Life Sciences - Outcome of Board Meeting

    In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has, at its meeting held on Wednesday, October 30, 2019 inter alia considered and approved: 1. Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2019 along with Limited Review Report of the Statutory Auditors thereon; 2. the appointment of Mr. Bhaskar Vemban Iyer (DIN:00480341) as an Additional and Independent Director of the Company for a period of five years with effect from October 30, 2019, subject to approval of the shareholders at the General Meeting of the Company. The meeting commenced at 12:00 noon and concluded at 4:00 p.m. Kindly take the above on record.

  • Oct 24, 2019 15:23 Source: BSE

    RPG Life Sciences - Announcement under Regulation 30 (LODR)-Newspaper Publication

    In terms of the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the newspaper notice published to give intimation of the meeting of Board of Directors of the Company scheduled to be held on October 30, 2019, inter alia, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2019. Kindly take this information on record.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Oct 30, 2019
Remark : Quarterly Results